Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hämophilie-Zentrum Rhein Main is a German specialty healthcare company and hemophilia center focused on the diagnosis, treatment, and research of congenital and acquired coagulation disorders, immune deficiencies, and hereditary angioedema. The organization operates as a physician-led center serving patients in the Rhine-Main region, with current contact operations in Frankfurt am Main. In addition to routine clinical care, HZRM appears to participate in clinical research and has been listed in rare-disease and clinical-trial directories. Its core activities are specialized outpatient care, diagnostic work-up, therapy management, and research support rather than proprietary drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hämophilie-Zentrum Rhein Main.